Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2a Multiple Ascending, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GFB-887, a TRPC5 Channel Inhibitor, in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04387448
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:54.527265+00:00
Published At
2022-11-15T00:00:00+00:00
Record Updated At
2022-11-15
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Kidney Diseases", "Diabetic Nephropathies", "Glomerulosclerosis, Focal Segmental", "Nephrosis, Lipoid", "Urologic Diseases", "Diabetes Complications", "Diabetes Mellitus", "Endocrine System Diseases", "Glomerulonephritis", "Nephritis", "Nephrosis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-11-15"
protocolSection.identificationModule.nctId
"NCT04387448"
protocolSection.identificationModule.officialTitle
"A Phase 2a Multiple Ascending, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GFB-887, a TRPC5 Channel Inhibitor, in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Kidney Diseases (protocolSection.conditionsModule.conditions)
  • Diabetic Nephropathies (protocolSection.conditionsModule.conditions)
  • Glomerulosclerosis, Focal Segmental (protocolSection.conditionsModule.conditions)
  • Nephrosis, Lipoid (protocolSection.conditionsModule.conditions)
  • Urologic Diseases (protocolSection.conditionsModule.conditions)
  • Diabetes Complications (protocolSection.conditionsModule.conditions)
  • Diabetes Mellitus (protocolSection.conditionsModule.conditions)
  • Endocrine System Diseases (protocolSection.conditionsModule.conditions)
  • Glomerulonephritis (protocolSection.conditionsModule.conditions)
  • Nephritis (protocolSection.conditionsModule.conditions)
  • Nephrosis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.